References
- Abdel-Rahman E, Bolton WK. (2002). Pimagedine: a novel therapy for diabetic nephropathy. Expert Opin Investig Drugs, 11, 565–574.
- Ariëns EJ. (1984). Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol, 26, 663–668.
- Belboukhari N, Cheriti A, Roussel C, Vanthuyne N. (2010). Chiral separation of hesperidin and naringin and its analysis in a butanol extract of Launeae arborescens. Nat Prod Res, 24, 669–681.
- Bergmeyer HU. (1984). Methods of Enzymatic Analysis (Third ed.), New York, USA: Academic Press, 136–139.
- Brand W, Shao J, Hoek-van den Hil EF, van Elk KN, Spenkelink B, de Haan LH, Rein MJ, Dionisi F, Williamson G, van Bladeren PJ, Rietjens IM. (2010). Stereoselective conjugation, transport and bioactivity of S- and R-hesperetin enantiomers in vitro. J Agric Food Chem, 58, 6119–6125.
- Caccamese S, Caruso C, Parrinello N, Savarino A. (2005). High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones. J Chromatogr A, 1076, 155–162.
- Fatima S, Jairajpuri DS, Saleemuddin M. (2008). A procedure for the rapid screening of Maillard reaction inhibitors. J Biochem Biophys Methods, 70, 958–965.
- Horvat S, Jakas A. (2004). Peptide and amino acid glycation: New insights into the Maillard reaction. J Pept Sci, 10, 119–137.
- Lv L, Shao X, Chen H, Ho CT, Sang S. (2011). Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol, 24, 579–586.
- Matsuda H, Wang T, Managi H, Yoshikawa M. (2003). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem, 11, 5317–5323.
- Matsuura N, Aradate T, Sasaki C, Kojima H, Ohara M, Hasegawa J, Ubukata M. (2002). Screening system for the Maillard reaction inhibitor from natural product extracts. J Health Sci, 48, 520–526.
- Miyake Y, Yamamoto K, Tsujihara N, Osawa T. (1998). Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids, 33, 689–695.
- Sasaki NA, Garcia-Alvarez MC, Wang Q, Ermolenko L, Franck G, Nhiri N, Martin MT, Audic N, Potier P. (2009). N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation. Bioorg Med Chem, 17, 2310–2320.
- Spencer JPE. (2008). Flavonoids: Modulators of brain function? Br J Nutr, 99, ES60–ES77.
- Thornalley PJ. (2005). Dicarbonyl intermediates in the Maillard reaction. Ann N Y Acad Sci, 1043, 111–117.
- Thornalley PJ, Langborg A, Minhas HS. (1999). Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J, 344 Pt 1, 109–116.
- Urios P, Grigorova-Borsos AM, Sternberg M. (2007). Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J Nutr, 46, 139–146.
- Vinson J, Howard T. (1996). Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem, 7, 659–663.